qCancer Colorectal is a NGS analysis that simultaneously analyzes 17 main genes associated with colon cancer risk. Colon cancer is the malignant tumor with the highest incidence in Spain, with about 30,000 new cases per year. It affects 1 in 20 men and 1 in 30 women before the age of 74. Most of these cases are sporadic but 30% are hereditary.
qCancer® Panels
The qCancer panels are qGenomics’ commitment to predictive and personalized medicine. Thanks to the use of NGS technology we are able to diagnose hereditary predispositions to develop tumors much more efficiently than before. Identifying individuals that have a higher risk of developing neoplasms is an approach to the medicine of the future, where cancer diagnoses will be diagnosed in increasingly earlier stages and where we can even avoid its manifestation. The knowledge of the carrier status of a mutation that predisposes for the development of certain neoplasms translates into benefits at different levels: medical controls adjusted to the risk of each individual, possibility of taking measures that allow us to prevent the onset of cancer and, in the case of affected people, a potential therapeutic benefit.
qGenomics offers the study of groups of genes associated with cancer risk based on the needs of specialists and their patients. These genes are analyzed by NGS techniques in combination with classical approaches of molecular genetics, when necessary.
